Reducing inappropriate, anticholinergic and psychotropic drugs among older residents in assisted living facilities: study protocol for a randomized controlled trial

Trials

Mikko Bjorkman¹  Harriet Finne-Soveri⁶  Mariko Teramura-Gronblad⁵  Hannu Kautiainen⁴  Marja-Liisa Laakkonen²  Helena Soini⁷  Anna-Liisa Juola⁸  Kaisu H Pitkala³ 

[1] Clinics of Internal Medicine and Geriatrics, Helsinki University Central Hospital, Haartmaninkatu 8 B, 00029, Helsinki, Finland;Helsinki Health Center, Laakso Hospital, Lääkärikatu 8, 00250, Helsinki, Finland;Unit of General Practice, Helsinki University Central Hospital and Department of General Practice, University of Helsinki, Tukholmankatu 8 B, 00014, University of Helsinki, Finland;Family Practice Unit, Central Finland Central Hospital, Jyväskylä, Finland and Primary Health Care Unit, Kuopio University Hospital, Hämeentie 1, 44100, Äänekoski, Finland;Home Nursing Services, Helsinki City Health Center, Siltasaarenkatu 2, 00500, Helsinki, Finland;National Institute for Health and Welfare, Lintulahdenkuja 4, 00271, Helsinki, Finland;Social Services Department, Services for Elderly, Health Center, Toinen linja 4 A, 00099, Helsinki, Finland;Kuusankoski Health Center, Kauppalankatu 14 3 krs, 45101, Kouvola, Finland

关键词: Randomized controlled trial;    Serviced housing;    Assisted living;    Polypharmacy;    Drug-drug interactions;    Anticholinergic drugs;    Psychotropic drugs;    Inappropriate drugs;   

Others  :  1095528
DOI  :  10.1186/1745-6215-13-85

 received in 2012-03-13, accepted in 2012-06-18,  发布年份 2012

【 授权许可】

   
2012 Pitkala et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Hosia-Randell HM, Muurinen SM, Pitkälä KH: Exposure to potentially inappropriate drugs and drug-drug interactions in elderly nursing home residents in Helsinki, Finland: a cross-sectional study. Drugs Aging 2008, 25:683-692.
• [2]Olsson J, Bergman A, Carlsten A, Oké T, Bernsten C, Schmidt IK, Fastbom J: Quality of drug prescribing in elderly people in nursing homes and special care units for dementia: a cross-sectional computerized pharmacy register analysis. Clin Drug Investig 2010, 30:289-300.
• [3]Onder G, Liperoti R, Fialova D, Topinkova E, Tosato M, Danese P, Gallo PF, Carpenter I, Finne-Soveri H, Gindin J, Bernabei R, Landi F: SHELTER project: polypharmacy in nursing home in Europe: results from the shelter study. J Gerontol A Biol Sci Med Sci 2012, 67A:698-704.
• [4]Hosia-Randell H, Pitkälä K: Use of psychotropic drugs in elderly nursing home residents with and without dementia in Helsinki, Finland. Drugs Ageing 2005, 22:793-800.
• [5]Field TS, Gurwitz JH, Avorn J, McCormick D, Jain S, Eckler M, Benser M, Bates DW: Risk factors for adverse drug events among nursing home residents. Arch Intern Med 2001, 161:1629-1634.
• [6]Hanlon JT, Schmader KE, Ruby CM, Weinberger M: Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc 2001, 49:200-209.
• [7]Socialstyrelsen: Indikatorer för god läkemedelsterapi hos äldre. Artikelnr 2010, 6:29. [ http://www.socialstyrelsen.se/publikationer2010/2010-6-29 webcite] Accessed 29 February 2012
• [8]Beers MH, Ouslander JG, Rollingher I, Reuben DB, Brooks J, Beck JC: Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine. Arch Intern Med 1991, 151:1825-832.
• [9]Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH: Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003, 163:2716-2724.
• [10]McLeod PJ, Huang AR, Tamblyn RM, Gayton DC: Defining inappropriate practices in prescribing for elderly people: a national consensus panel. Can Med Assoc J 1997, 156:385-391.
• [11]Gallagher P, O'Mahony D: STOPP (Screening tool of older persons' potentially inappropriate prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing 2008, 37:673-679.
• [12]Spinewine A, Schmader KE, Barber N, Hughes C, Lapane KL, Swine C, Hanlon JT: Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 2007, 370:173-184.
• [13]Raivio MM, Laurila JV, Strandberg TE, Tilvis RS, Pitkala KH: Use of inappropriate medications and their prognostic significance in hospital and nursing home patients with and without dementia in Finland. Drugs Aging 2006, 23:333-343.
• [14]Lau DT, Kasper JD, Potter DE, Lyles A: Potentially inappropriate medication prescriptions among elderly nursing home residents: their scope and associated resident and facility characteristics. Health Serv Res 2004, 39:1257-1276.
• [15]Stafford AC, Alswayan MS, Tenni PC: Inappropriate prescribing in older residents of Australian care homes. J Clin Pharm Ther 2011, 36:33-44.
• [16]Jano E, Aparasu RR: Healthcare outcomes associated with Beers' criteria: a systematic review. Ann Pharmacother 2007, 41:438-447.
• [17]Borson S, Doane K: The impact of OBRA-87 on psychotropic drug prescribing in skilled nursing facilities. Psychiatr Serv 1997, 48:1289-1296.
• [18]Schneider LS, Dagerman KS, Insel P: Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA 2005, 294:1934-1943.
• [19]Wang PS, Schneeweiss S, Avorn J, Fischer MA, Mogun H, Solomon DH, Brookhart MA: Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med 2005, 353:2335-2341.
• [20]Hartikainen S, Lönnroos E, Louhivuori K: Medication as a risk factor for falls: critical systematic review. J Gerontol A Biol Sci Med Sci 2007, 62:1172-1181.
• [21]Ancelin ML, Artero S, Portet F, Dupuy AM, Touchon J, Ritchie K: Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ 2006, 332:455-9.
• [22]Uusvaara J, Pitkala KH, Tienari PJ, Kautiainen H, Tilvis RS, Strandberg TE: Association between anticholinergic drugs and apolipoprotein e ε4 allele and poorer cognitive function in older cardiovascular patients: a cross-sectional study. J Am Geriatr Soc 2009, 57:427-431.
• [23]Uusvaara J, Pitkala KH, Kautiainen H, Tilvis RS, Strandberg TE: Association of anticholinergic drugs with hospitalization and mortality among older cardiovascular patients: a prospective study. Drugs Aging 2011, 28:131-138.
• [24]Rudolph JL, Salow MJ, Angelini MC, McGlinchey RE: The anticholinergic risk scale and anticholinergic adverse effects in older persons. Arch Intern Med 2008, 168:508-513.
• [25]Bell S, Strandberg TE, Teramura-Gronblad M, Laurila JV, Tilvis RS, Pitkala KH: Use of proton-pump inhibitors and mortality among institutionalized older people. Arch Intern Med 2010, 170:1604-1605.
• [26]Johnell K, Klarin I: The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register. Drug Saf 2007, 30:911-918.
• [27]SFINX - Lääkeaineiden yhteisvaikutukset (Swedish, Finnish, INteraction X-referencing) [ http://www.terveysportti.fi/terveysportti/ia_yhteisvaikutus.koti webcite] Accessed 29 February 2012
• [28]Forsetlund L, Eike MC, Gjerberg E, Vist GE: Effect of interventions to reduce potentially inappropriate use of drugs in nursing homes: a systematic review of randomised controlled trials. BMC Geriatr 2011, 11:16. BioMed Central Full Text
• [29]Avorn J, Soumerai SB, Everitt DE, Ross-Degnan D, Beers MH, Sherman D, Salem-Schatz SR, Fields D: A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes. N Engl J Med 1992, 327:168-173.
• [30]Meador KG, Taylor JA, Thapa PB, Fought RL, Ray WA: Predictors of antipsychotic withdrawal or dose reduction in a randomized controlled trial of provider education. J Am Geriatr Soc 1997, 45:207-210.
• [31]Fossey J, Ballard C, Juszczak E, James I, Alder N, Jacoby R, Howard R: Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial. BMJ 2006, 332:756-761.
• [32]Crotty M, Halbert J, Rowett D, Giles L, Birks R, Williams H, Whitehead C: An outreach geriatric medication advisory service in residential aged care: a randomised controlled trial of case conferencing. Age Ageing 2004, 33:612-617.
• [33]Patterson SM, Hughes CM, Crealey G, Cardwell C, Lapane KL: An evaluation of an adapted U.S. model of pharmaceutical care to improve psychoactive prescribing for nursing home residents in Northern Ireland (Fleetwood Northern Ireland study). J Am Geriatr Soc 2010, 58:44-53.
• [34]Roberts MS, Stokes JA, King MA, Lynne TA, Purdie DM, Glasziou PP, Wilson DA, McCarthy ST, Brooks GE, de Looze FJ, Del Mar CB: Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol 2001, 51:257-265.
• [35]Crotty M, Rowett D, Spurling L, Giles LC, Phillips PA: Does the addition of a pharmacist transition coordinator improve evidence-based medication management and health outcomes in older adults moving from the hospital to a long-term care facility? Results of a randomized, controlled trial. Am J Geriatr Pharmacother 2004, 2:257-264.
• [36]Folstein MF, Folstein SE, McHugh PR: "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975, 12:189-198.
• [37]Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL: A new clinical scale for the staging of dementia. Br J Psychiatry 1982, 140:566-572.
• [38]Morris JC, Heyman A, Mohs RC, Hughes JP, van Belle G, Fillenbaum G, Mellits ED, Clark C: The consortium to establish a registry for Alzheimer's disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 1989, 39:1159-1165.
• [39]Welsh K, Butters N, Hughes J, Mohs R, Heyman A: Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Arch Neurol 1991, 48:278-281.
• [40]Sunderland T: Hill JL, Mellow AM, Lawlor BA, Gundersheimer J, Newhouse PA. Grafman JH: Clock drawing in Alzheimer's disease. A novel measure of dementia severity. J Am Geriatr Soc 1989, 37:725-729.
• [41]Guigoz Y, Lauque S: Vellas BJ: Identifying the elderly at risk for malnutrition. The Mini Nutritional Assessment. Clin Geriatr Med 2002, 18:737-757.
• [42]Routasalo PE, Tilvis RS, Kautiainen H, Pitkala KH: Effects of psychosocial group rehabilitation on social functioning, loneliness and well-being of lonely, older people: randomized controlled trial. J Adv Nurs 2009, 65:297-305.
• [43]Sintonen H: The 15D instrument of health-related quality of life: properties and applications. Ann Med 2001, 33:328-336.
• [44]WHO Collaborating Centre for Drug Statistics Methodology: Anatomical therapeutic chemical classification system. ATC/DDD Index 2012. [ http://www.whocc.no/atc_ddd_index/ webcite] Accessed 1 March 2012
• [45]Morris JN, Fries BE, Bernabei R, Ikegami R, Carpenter I, Gilgen R, DuPasquier J, Frijters D, Henrard J, Hirdes JP, Belleville-Taylor P: RAI-home care (RAI-HC) assessment manual for version 2.0. Marblehead, MA: Opus Communications; 2000.
• [46]Leikola S: Development and application of comprehensive medication review procedure to community-dwelling elderly. Dissertationes Biocentri Viikki Universitatis Helsingiensis. Helsinki University Printing House 2012, 48:65. Helsinki, Finland